Ariel Southeast Angel Partners logo

Ariel Southeast Angel Partners

North America, Georgia, United States, Savannah

Description

Ariel Southeast Angel Partners is an angel investment group that supports start-up and early stage companies.

Investor Profile

Ariel Southeast Angel Partners has backed more than 7 startups, with 0 new investments in the last 12 months alone. The firm has led 1 rounds, about 14% of its total and boasts 1 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Series A, Series B, Series Unknown rounds (top funding stages).
  • Majority of deals are located in United States.
  • Strong thematic focus on Health Care, Medical Device, Biotechnology.

Stage Focus

  • Series A (43%)
  • Series B (14%)
  • Series Unknown (14%)
  • Convertible Note (14%)
  • Pre Seed (14%)

Country Focus

  • United States (100%)

Industry Focus

  • Health Care
  • Medical Device
  • Biotechnology
  • Therapeutics
  • Wellness
  • Life Science
  • Medical
  • Artificial Intelligence (Ai)
  • Machine Learning
  • Pharmaceutical
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Ariel Southeast Angel Partners frequently co-invest with?

MP
North America, Pennsylvania, United States, Villanova
Co-Investments: 1
Dolby Family Ventures
North America, California, United States, San Francisco
Co-Investments: 1
Boston Harbor Angels
North America, Massachusetts, United States, Boston
Co-Investments: 2
Cowtown Angels
North America, Texas, United States, Fort Worth
Co-Investments: 1
Keiretsu Forum
North America, California, United States, Orinda
Co-Investments: 2
Accelerator Fund
North America, Pennsylvania, United States, Pittsburgh
Co-Investments: 1
Tech Coast Angels
North America, California, United States, Newport Beach
Co-Investments: 2
Mid Atlantic Bio Angels
North America, New York, United States, New York
Co-Investments: 2
Golden Seeds
North America, New York, United States, Flushing
Co-Investments: 2
New York Angels
North America, New York, United States, New York
Co-Investments: 3

Which angels does Ariel Southeast Angel Partners often collaborate with?

GZ
North America, Massachusetts, United States, Plymouth
Shared Deals: 1
Shared Deals: 1
EA
North America, New Hampshire, United States, Portsmouth
Shared Deals: 1
JH
North America, Massachusetts, United States, Boston
Shared Deals: 1

What are some of recent deals done by Ariel Southeast Angel Partners?

Skintelligent

Atlanta, Georgia, United States

Skintelligent is a Developing Advanced AI SkinTech Solutions for Health Care & Skin Care

Artificial Intelligence (AI)Health CareMachine Learning
Pre SeedSep 15, 2021
Amount Raised: $250,000
Zylö Therapeutics

Greenville, South Carolina, United States

Zylö Therapeutics offers an innovative sustained-release drug-delivery system.

Health CarePharmaceuticalTherapeutics
Series ASep 26, 2019
Amount Raised: $4,000,000
New View Surgical

Boston, Massachusetts, United States

New View Surgical is a medical device company focused on the commercialization of novel surgical imaging and access systems for MIS.

Health CareMedical DeviceWellness
Series AJun 17, 2019
Amount Raised: $2,100,000
RevBio

Lowell, Massachusetts, United States

RevBio was started with one goal in mind—to end medicine’s 50-year search for a biocompatible bone adhesive.

BiotechnologyHealth CareMedicalMedical Device
Convertible NoteJul 1, 2018
Amount Raised: $4,000,000
Respiratory Motion

Watertown, Massachusetts, United States

Respiratory Motion is a commercial-stage medical device company.

BiotechnologyHealth CareMedical Device
Series UnknownJul 13, 2017
New View Surgical

Boston, Massachusetts, United States

New View Surgical is a medical device company focused on the commercialization of novel surgical imaging and access systems for MIS.

Health CareMedical DeviceWellness
Series AMar 1, 2017
Amount Raised: $2,540,000
Cognition Therapeutics

Pittsburgh, Pennsylvania, United States

Cognition Therapeutics develops new therapeutics to treat patients suffering from Alzheimer’s disease and other neurodegenerative disorders.

BiotechnologyHealth CareLife ScienceTherapeutics
Series BSep 8, 2015
Amount Raised: $12,000,000